NCT03219931View on ClinicalTrials.gov

NEOBIFI: Clinical Trial for the Prevention and/or Reduction of the Incidence of Colics in Infants

PHASE4CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

October 1, 2013

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Colic, InfantileProbioticGut MicrobiomeBifidobacterium Breve
Interventions
DRUG

Bifidobacterium breve BR03 and Bifidobacterium breve B632

This is the active product containing 108 viable cells/strain

DRUG

Placebos

This is the placebo product containing a similar product without bifidobacterium inside.

Trial Locations (1)

28100

AOU Maggiore della Carità - Clinica Pediatrica - Ambulatorio di Gastroenterologia Pediatrica, Novara

All Listed Sponsors
lead

Azienda Ospedaliero Universitaria Maggiore della Carita

OTHER

NCT03219931 - NEOBIFI: Clinical Trial for the Prevention and/or Reduction of the Incidence of Colics in Infants | Biotech Hunter | Biotech Hunter